Clinical outcome analysis of patients with autism spectrum disorder: analysis from the UK Medical Cannabis Registry
Introduction: Cannabis-based medicinal products (CBMPs) have been identified as a promising novel therapeutic for symptoms and comorbidities related to autism spectrum disorder (ASD). However, there is a paucity of clinical evidence of their efficacy and safety. Objective: This case series aims to a...
Saved in:
Main Authors: | Simon Erridge (Author), Jess Kerr-Gaffney (Author), Carl Holvey (Author), Ross Coomber (Author), Daniela A. Riano Barros (Author), Urmila Bhoskar (Author), Gracia Mwimba (Author), Kavita Praveen (Author), Chris Symeon (Author), Simmi Sachdeva-Mohan (Author), Mikael H. Sodergren (Author), James J. Rucker (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
UK Medical Cannabis Registry: An analysis of clinical outcomes of medicinal cannabis therapy for attention‐deficit/hyperactivity disorder
by: Pim Ittiphakorn, et al.
Published: (2023) -
A cohort study comparing the effects of medical cannabis for anxiety patients with and without comorbid sleep disturbance
by: Matthew Murphy, et al.
Published: (2024) -
An observational study of clinical outcome measures in patients treated with cannabis‐based medicinal products on the UK Medical Cannabis Registry
by: Simon Erridge, et al.
Published: (2023) -
An initial analysis of the UK Medical Cannabis Registry: Outcomes analysis of first 129 patients
by: Simon Erridge, et al.
Published: (2021) -
UK Medical Cannabis Registry palliative care patients cohort: initial experience and outcomes
by: Devaki Nimalan, et al.
Published: (2022)